News | May 27, 2021
Cadila Healthcare posts consolidated PAT of Rs. 679 Cr
Cadila Healthcare has reported total income of Rs.15139.4 crores FY 2020-21
Cadila Healthcare has reported total income of Rs.15139.4 crores FY 2020-21
Targeted production of the dual vector Sputnik V for the first 12 months is 50 million doses from the date of start of commercial production
The company plans to aggressively invest in longer gestation period projects like innovation, biosimilars, vaccines, etc.
Report outlines the wide array of investment opportunities in various segments of India’s healthcare sector
The company's business in India geography posted strong growth during the quarter as it grew by 20% on a y-o-y basis and registered revenues of Rs. 1,643 crore.
The commercial production in the SML was started in November 1989.
Over the course of his career, he has also held leadership roles at Pfizer, Alembic Pharmaceuticals, and Cipla
In his new role, he will lead the company's growth strategy across Africa, strengthen healthcare partnerships, and expand access to innovative diagnostic solutions
Partnership with Sunshine Healthcare aims to build local pharmaceutical capabilities and strengthen supply chain resilience
Experts announce upcoming Amyotrophic lateral sclerosis (ALS) studies, advocate early diagnosis, comprehensive care, and stronger support systems for patients and caregivers
Subscribe To Our Newsletter & Stay Updated
